HEALDO INC – Trademark Portfolio

Entity Type: 03

HEALDO INC owns a portfolio of 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as FUNERMY, HERDEMIA, and CENFFITIO. Of these, 4 are registered and 3 are pending. The portfolio spans 3 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 1 (Chemicals). Headquartered in 156 WILMINGTON, DE.

1230 NORTH KING ST

156 WILMINGTON, DE 19801

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

HEALDO INC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

30
Staple Foods (2 filings)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does HEALDO INC have?

HEALDO INC has 7 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 pending.

What trademark classes does HEALDO INC file in?

HEALDO INC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are HEALDO INC's most well-known trademarks?

HEALDO INC's registered trademark portfolio includes well-known marks such as FUNERMY, HERDEMIA, and CENFFITIO. These are among 4 currently registered trademarks in the portfolio.

What is HEALDO INC's trademark registration success rate?

HEALDO INC has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 3 applications are pending review.